Results 171 to 180 of about 53,380 (285)

Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy

open access: yesVascular Health and Risk Management, 2007
Christoph Schindler1, Peter Bramlage1, Wilhelm Kirch1, Carlos M Ferrario21Institute of Clinical Pharmacology, Medical Faculty, Technical University of Dresden, Dresden, Germany; 2Hypertension and Vascular Disease Center, Wake Forest University, School of
Christoph Schindler   +3 more
doaj  

Studies on Agents with Vasodilator and .BETA.-Blocking Activities. V. Synthesis and Pharmacological Activity of the Optical Isomers of TZC-5665.

open access: bronze, 1998
Tomohisa Seki   +9 more
openalex   +2 more sources

Novel Non‐Hyperemic Coronary Physiology Indices for Vessel Longitudinal Analysis

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2374-2385, October 1, 2025.
ABSTRACT Background Physiological pattern of coronary artery disease, whether focal or diffuse, is critical in guiding physicians during the decision‐making process for percutaneous coronary interventions. Aims This study introduces two novel non‐hyperemic coronary physiology indices designed for longitudinal vessel analysis.
Simone Fezzi   +13 more
wiley   +1 more source

The Glycocalyx: Barriers and Opportunities at Cell–Cell Encounters

open access: yesProteoglycan Research, Volume 3, Issue 4, October 2025.
ABSTRACT The glycocalyx, a carbohydrate‐rich, gel‐like layer that coats every mammalian cell, is the first point of contact between cells in tissues. It therefore critically influences these encounters, impacting their mechanical, electrical, and chemical features that ultimately determines the outcome of cell–cell contacts.
Lucas C. Wyss, Spencer A. Freeman
wiley   +1 more source

Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise‐Related Dyspnea in COPD‐PH (BETTER COPD‐PH)

open access: yesPulmonary Circulation, Volume 15, Issue 4, October 2025.
ABSTRACT Dyspnea, a debilitating symptom of COPD, worsens health‐related quality of life (HRQL), reduces daily physical activity, increases health care utilization, and is more closely associated with survival than airflow limitation. Thus, having treatments that reduce dyspnea in COPD is important.
Elena DeSanti   +40 more
wiley   +1 more source

Decoding the coronary paradox of obesity: not all fat is equal! [PDF]

open access: yesInt J Cardiol Heart Vasc
Santulli G, Pande S, Mone P, Varzideh F.
europepmc   +1 more source

Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy

open access: yesPulmonary Circulation, Volume 15, Issue 4, October 2025.
ABSTRACT Pulmonary perfusion assessment is essential for the management of chronic thromboembolic pulmonary hypertension (CTEPH). Lung perfusion scintigraphy and contrast‐enhanced CT are occasionally limited by the need for radionuclides or allergy to the contrast agents.
Megumi Ikeda   +13 more
wiley   +1 more source

Prostacyclin Therapy as Adjunctive Treatment for Pulmonary Hypertension in Pediatric Heart Transplantation: A Case Report. [PDF]

open access: yesPediatr Transplant
Konduri A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy